Source: MedicalNewsToday.com A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck & Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine. Study lead author Dr Chun [...]
Continue reading...Thursday, January 5, 2012
Source: The ASCO Post, January 1, 2012, Volume 3, Issue 1, Matthew Stenger In the Clinic provides overviews of novel oncology agents, addressing indications, mechanisms, administration recommendations, safety profiles, and other essential information needed for the appropriate clinical use of these drugs.Cetuximab (Erbitux) was recently approved by the FDA for use in combination with platinum-based therapy [...]
Continue reading...Thursday, December 8, 2011
Source: The Daily Iowan The Nov. 29 editorial “Recommend Pap smears, not vaccines, to prevent cervical cancer” completely missed the mark with regard to HPV vaccines. We are researchers and clinicians at the University of Iowa who study and treat HPV and other infectious diseases. It is disturbing to think that the article might dissuade [...]
Continue reading...Wednesday, November 30, 2011
Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]
Continue reading...Tuesday, November 22, 2011
Source: Convenience Store News WINSTOM-SALEM, N.C. — Since starting a second round of testing, R.J. Reynolds Tobacco Co.’s dissolvable tobacco products are proving popular among women. The product line — Camel Sticks, Camel Strips and Camel Orbs –do not require spitting, which could be a deciding factor among female tobacco users. According to a report [...]
Continue reading...Wednesday, November 9, 2011
Source: www.pharmabiz.com Author: staff The US Food and Drug Administration (FDA) has approved Erbitux (cetuximab), in combination with platinum-based chemotherapy with 5-fluorouracil (CT), for the first-line treatment of recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN). The approval, which is based on data from the landmark EXTREME (ErbituX in first-line [...]
Continue reading...Tuesday, November 8, 2011
Source: The New York Times If you want a truly frustrating job in public health, try getting people to stop smoking. Even when researchers combine counseling and encouragement with nicotine patches and gum, few smokers quit. Recently, though, experimenters in Italy had more success by doing less. A team led by Riccardo Polosa of the [...]
Continue reading...Tuesday, November 8, 2011
Source: MedScape News Today The US Food and Drug Administration (FDA) has approved cetuximab (Erbitux, Bristol-Myers Squibb ) for use in combination with chemotherapy for the treatment of metastatic head and neck cancer. Data show that when combined with cisplatin-based chemotherapy, cetuximab improved overall survival, compared with chemotherapy alone. According to the researchers, this is [...]
Continue reading...Tuesday, October 25, 2011
Source: CNN.com A federal government advisory committee voted Tuesday to recommend that boys and young men, from ages 11 to 21, be vaccinated against the human papilloma virus, commonly referred to as HPV. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices says the vaccine series can be started as early as [...]
Continue reading...Thursday, September 29, 2011
Source: USA Today Tobacco companies knew for decades that cigarette smoke was radioactive and potentially carcinogenic but kept that information from the public, according to a new study. The tobacco industry began investigations into the possible effects of these radioactive particles, identified as polonium-210, on smokers as early as the 1960s, says the study by UCLA [...]
Continue reading...
Friday, February 3, 2012
0 Comments